Skip to Content
Merck
CN

HT17MG-14K-PX25

MILLIPLEX® Human Th17 Panel

Premixed Human Th17 25-Plex Panel

Synonym(s):

Human Th17 cytokine multiplex kit, Luminex® human Th17 cytokine immunoassay, Millipore human Th17 cytokine panel

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12161503
NACRES:
NA.47
eCl@ss:
32161000
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

MILLIPLEX® Human Th17 Panel,

description

Premixed Human Th17 25-Plex Panel

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

accuracy: 79-107%, standard curve range: 1-5000 pg/mL
(IL-10), standard curve range: 10-40,000 pg/mL
(IFNγ), standard curve range: 12-50,000 pg/mL
(IL-17A & IL-2), standard curve range: 24-100,000 pg/mL
(IL-17 & IL-4), standard curve range: 3-10,000 pg/mL
(IL-6 & TNFα), standard curve range: 336-1,500,000 pg/mL
(IL-23), standard curve range: 37-150,000 pg/mL
(IL-22 & TNFβ), standard curve range: 488-2,000,000 pg/mL
(IL-17E/IL-25), standard curve range: 49-200,000 pg/mL
(IL-28a & IL-31), standard curve range: 5-20,000 pg/mL
(MIP-3α, IL-1β, IL-12 (p70), IL-15, IL-21 & IL-33), standard curve range: 6-25,000 pg/mL
(IL-5), standard curve range: 61-250,000 pg/mL
(GM-CSF & IL-27), standard curve range: 7-30,000 pg/mL
(IL-13), standard curve range: 9-35,000 pg/mL
(IL-9)

technique(s)

multiplexing: suitable

input

cell culture supernatant(s)
serum
plasma

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

CD4 T-helper cells are major players in adaptive immunity. Based on their expression profile of transcription factors and secreted cytokines, these cells are divided into the major subsets Th1, Th2, Th17 and T regulatory (Treg) cells. Th1 cells, induced by IL-12 and enhanced by IFNγ, secrete IFNγ that activates macrophages. Induced by IL-4, Th2 cells primarily produce IL-4, IL-5, IL-13, IL-25 and IL-17E, playing a role in allergy. Treg cells, induced by TGFβ, produce the anti-inflammatory cytokines IL-10 and TGFβ and function to control T-cell responses to prevent autoimmune reactions. Th17 cells, a more recently discovered subset characterized by the production of IL-17, are induced by TGFβ combined with IL-23 and IL-1β in humans, and TGFβ, IL-6 and IL-21 in mice. Activated Th17 cells secrete IL-17A, IL-17F, IL-21, IL-22 and TNFα to promote tissue inflammation. Th17 cells are involved in the clearance of extracellular bacteria and fungi. They are abundant in the intestinal lamina propria and function as a barrier against invading pathogens. Excessive amounts of Th17 cells have been implicated in the pathogenesis of several autoimmune diseases, including multiple sclerosis, psoriasis, juvenile diabetes, rheumatoid arthritis, Crohn′s disease, and autoimmune uveitis. In addition, Th17 cells play an important role in tumor development, progression, and metastasis, potentially in both promoting and inhibiting tumor growth.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze 25 analytes in human serum, plasma, and cell culture supernatants.

Analytes included: GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17A, IL-17F, IL-17E/IL-25, IL-21, IL-22, IL-23, IL-27, IL-28A, IL-31, IL-33, MIP-3α/CCL20, TNF-α, TNFβ

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

  • Multiplex Capability: The panel allows for the simultaneous quantification of multiple Th17-related cytokines, enhancing efficiency in data collection.
  • Standardized Protocol: Includes a comprehensive and easy-to-follow protocol, facilitating consistent and reproducible results across different laboratory settings.
  • Comprehensive Cytokine Profiling: By measuring multiple Th17 cytokines in one assay, researchers can gain a deeper understanding of the Th17 immune response and its role in various diseases.
  • Time and Resource Efficiency: The ability to run multiple assays in parallel saves time and conserves sample volume, making it ideal for studies with limited sample availability.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


Still not finding the right product?

Explore all of our products under MILLIPLEX® Human Th17 Panel


signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

Storage Class

10 - Combustible liquids

wgk

WGK 3

Regulatory Information

新产品

This item has



Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Gyoung Nyoun Kim et al.
PLoS pathogens, 17(12), e1010092-e1010092 (2021-12-17)
The development of safe and effective vaccines to prevent SARS-CoV-2 infections remains an urgent priority worldwide. We have used a recombinant vesicular stomatitis virus (rVSV)-based prime-boost immunization strategy to develop an effective COVID-19 vaccine candidate. We have constructed VSV genomes
Leena P Bharath et al.
Cell metabolism, 32(1), 44-55 (2020-05-14)
Age is a non-modifiable risk factor for the inflammation that underlies age-associated diseases; thus, anti-inflammaging drugs hold promise for increasing health span. Cytokine profiling and bioinformatic analyses showed that Th17 cytokine production differentiates CD4+ T cells from lean, normoglycemic older and